Skip to main content

Rheumatoid Arthritis clinical trials at UCSF

6 in progress, 3 open to eligible people

Showing trials for
  • Defining Stress REsilience And Mindfulness Effects in Rheumatoid Arthritis

    open to eligible people ages 18 years and up

    This clinical trial will test a mindfulness program in individuals with rheumatoid arthritis (RA). The main goals of this pilot study are to: - Assess patient satisfaction with a mindfulness course - Identify barriers to participation in, or completion of, a mindfulness course - Gather initial information to understand how a mindfulness course impacts RA symptoms Participants will: - Complete online questionnaires - Attend two in-person study visits, involving a brief joint exam and blood draw - Roughly half the participants will have the chance to participate in an 8-week online mindfulness course - Roughly half the participants will be invited to participate in an online focus group following completion of the mindfulness course Researchers will compare those in the mindfulness course with those receiving standard care in preparation for a larger future study to see how mindfulness impacts stress and inflammation in individuals with RA.

    San Francisco, California

  • Rheumatoid Arthritis Shared Decision Making

    open to eligible people ages 18 years and up

    Shared decision making is the first overarching principle for the treat to target guidelines for rheumatoid arthritis (RA) and has been proposed as a potential mechanism to reduce health disparities, however there is little evidence to inform effective ways to implement this practice in the care of Veterans with RA. The purpose of this project is to evaluate the effectiveness of a multi-component shared decision making intervention on RA disease activity, adherence to RA medications and patient knowledge of RA. The proposed research will contribute to fundamental knowledge about how to effectively foster shared decision making across varied VA rheumatology clinical settings to improve patient disease outcomes and experience; and support clinicians to engage patients in meaningful ways with the ultimate goal to improve health, reduce disability, and eliminate disparities.

    San Francisco, California and other locations

  • Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA

    open to eligible people ages 18 years and up

    This study will confirm the ability of Tc 99m tilmanocept imaging to predict clinical response in individuals with RA who are beginning anti-TNFα therapy.

    San Francisco, California and other locations

  • Zr-89 Cimzia PET Imaging Rheumatoid Arthritis

    Sorry, currently not accepting new patients, but might later

    This is a single center exploratory imaging study investigating the initial application of zirconium-89 Deferoxamine B Certolizumab pegol (89Zr-DFO-CZP) PET in patients with rheumatoid arthritis. Patients with active symptoms of RA or signs on physical exam will be invited to participate for PET imaging.

    San Francisco, California

  • CD40L Antagonism in Rheumatoid Arthritis (RA)

    Sorry, in progress, not accepting new patients

    The primary objective is to determine if the addition of a 12-week course of treatment with VIB4920 to TNFi treatment will result in improved clinical disease control in patients with RA who have had an inadequate response to a TNFi.

    San Francisco, California and other locations

  • Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System

    Sorry, in progress, not accepting new patients

    The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty.

    San Francisco, California and other locations

Our lead scientists for Rheumatoid Arthritis research studies include .

Last updated: